Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic Alzheimer's disease in a Japanese population

Neuroscience Letters

Volumn 379, Issue 3, 2005, Pages 149-151

  Tamura, Yoshiko ^a   Sakasegawa, Yuji ^a   Omi, Kazuya ^a,b   Kishida, Hitaru ^a,c   Asada, Takashi ^d   Kimura, Hideo ^a   Tokunaga, Katsushi ^b   Hachiya, Naomi S ^a   Kaneko, Kiyotoshi ^a   Hohjoh, Hirohiko ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Alzheimer' disease; Association study; Chemokine; CXC motif, ligand 1 (CXCL1); Single nucleotide polymorphisms (SNPs)

Indexed keywords

ALPHA CHEMOKINE; APOLIPOPROTEIN E4; CXCL1 CHEMOKINE; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; ASIAN; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

EID: 20244364386     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.12.056     Document Type: Article

References (17)

1. A. Bajetto, R. Bonavia, S. Barbero, T. Florio, and G. Schettini Chemokines and their receptors in the central nervous system Front Neuroendocrinol. 22 2001 147 184
2. D. Blacker, L. Bertram, A.J. Saunders, T.J. Moscarillo, M.S. Albert, H. Wiener, R.T. Perry, J.S. Collins, L.E. Harrell, R.C. Go, A. Mahoney, T. Beaty, M.D. Fallin, D. Avramopoulos, G.A. Chase, M.F. Folstein, M.G. McInnis, S.S. Bassett, K.J. Doheny, E.W. Pugh, and R.E. Tanzi Results of a high-resolution genome screen of 437 Alzheimer's disease families Hum. Mol. Genet. 12 2003 23 32
3. R. Bonavia, A. Bajetto, S. Barbero, P. Pirani, T. Florio, and G. Schettini Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation Toxicol. Lett. 139 2003 181 189
4. C.M. Coughlan, C.M. McManus, M. Sharron, Z. Gao, D. Murphy, S. Jaffer, W. Choe, W. Chen, J. Hesselgesser, H. Gaylord, A. Kalyuzhny, V.M. Lee, B. Wolf, R.W. Doms, and D.L. Kolson Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons Neuroscience 97 2000 591 600
5. L. Excoffier, and M. Slatkin Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population Mol. Biol. Evol. 12 1995 921 927
6. D. Fallin, A. Cohen, L. Essioux, I. Chumakov, M. Blumenfeld, D. Cohen, and N.J. Schork Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease Genome Res. 11 2001 143 151
7. J.K. Harrison, C.M. Barber, and K.R. Lynch cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors Neurosci. Lett. 169 1994 85 89
8. J.K. Harrison, Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R.K. McNamara, W.J. Streit, M.N. Salafranca, S. Adhikari, D.A. Thompson, P. Botti, K.B. Bacon, and L. Feng Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia Proc. Natl. Acad. Sci. U.S.A. 95 1998 10896 10901
9. R. Horuk, A.W. Martin, Z. Wang, L. Schweitzer, A. Gerassimides, H. Guo, Z. Lu, J. Hesselgesser, H.D. Perez, J. Kim, J. Parker, T.J. Hadley, and S.C. Peiper Expression of chemokine receptors by subsets of neurons in the central nervous system J. Immunol. 158 1997 2882 2890
10. S.M. Laws, E. Hone, S. Gandy, and R.N. Martins Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription J. Neurochem. 84 2003 1215 1236
11. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
12. M. Michikawa, and K. Yanagisawa Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis J. Neurosci. Res. 54 1998 58 67
13. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, and M.J. Alberts Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
14. M. Xia, and B.T. Hyman GROalpha/KC a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation - a role in Alzheimer's disease? J. Neuroimmunol. 122 2002 55 64
15. M. Xia, S. Qin, M. McNamara, C. Mackay, and B.T. Hyman Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease Am. J. Pathol. 150 1997 1267 1274
16. M.Q. Xia, B.J. Bacskai, R.B. Knowles, S.X. Qin, and B.T. Hyman Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease J. Neuroimmunol. 108 2000 227 235
17. M.Q. Xia, and B.T. Hyman Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease J. Neurovirol. 5 1999 32 41